Joe C Mathew / New Delhi September 06, 2008, 3:59 IST Data on clinical trials of genetically-modified (GM) brinjal have been made public by the Genetic Engineering Approval Committee (GEAC) of the environment ministry. The development comes even as Maharashtra Hybrid Seeds Company (Mahyco) had filed a petition before the Delhi High Court to prevent disclosure of the details of clinical trials on GM brinjal by the Review Committee on Genetic Modification of the Department of Biotechnology (DBT). Since the Mahyco litigation is considered by the industry as well as public interest groups as a test case for deciding the fate of exclusive data shared by companies, especially pharmaceutical and agri-business entities, with the government for regulatory approvals, the GEAC decision has raised questions about the